Literature DB >> 21931235

Perceptions of reimbursement for clinical trial participation.

Carmen Radecki Breitkopf1, Melissa Loza, Kathleen Vincent, Thomas Moench, Lawrence R Stanberry, Susan L Rosenthal.   

Abstract

A greater understanding of participant views regarding reimbursement will help investigators plan studies that have better potential for reaching target enrollment, maximize efficient recruitment, maintain scientific integrity, and enhance retention over time. As part of a clinical trial in the area of sexual health, healthy women's perceptions of reimbursement for research participation were investigated. Semi-structured, audio-recorded, qualitative interviews were conducted immediately upon women's completion of the clinical trial to enable a participant-driven understanding of perceptions about monetary reimbursement. Audio-recordings were transcribed and analyzed using framework analysis. Women (N = 30) had a mean age of 29.5 ± 5.7 years (range 22-45 years). Sixty-three percent of participants (n = 19) were non-Hispanic (white n = 13, black n = 4, and Asian n = 2), while the remaining were Hispanic (n = 11). Seventy-three percent (n = 22) reported previous participation in research. In general, women viewed reimbursement as a benefit to research participation, the amount of which should reflect time, the inconvenience to the research subject, and the potential for unknown risks in the short- and long-term. They believed reimbursement should take into account the degree of risk of the study, with investigations of experimental products offering greater reimbursement. Women believed that monetary reimbursement is unlikely to coerce an individual to volunteer for a study involving procedures or requirements that they found unacceptable. The results of this study can be used to provide guidance to those planning and evaluating reimbursement for research participation.

Entities:  

Mesh:

Year:  2011        PMID: 21931235      PMCID: PMC3278858          DOI: 10.1525/jer.2011.6.3.31

Source DB:  PubMed          Journal:  J Empir Res Hum Res Ethics        ISSN: 1556-2646            Impact factor:   1.742


  21 in total

1.  Do research payments precipitate drug use or coerce participation?

Authors:  David S Festinger; Douglas B Marlowe; Jason R Croft; Karen L Dugosh; Nicole K Mastro; Patricia A Lee; David S Dematteo; Nicholas S Patapis
Journal:  Drug Alcohol Depend       Date:  2005-01-23       Impact factor: 4.492

2.  Application of optical coherence tomography for monitoring changes in cervicovaginal epithelial morphology in macaques: potential for assessment of microbicide safety.

Authors:  Kathleen L Vincent; Brent A Bell; Susan L Rosenthal; Lawrence R Stanberry; Nigel Bourne; Yvonne T Cosgrove Sweeney; Dorothy L Patton; Massoud Motamedi
Journal:  Sex Transm Dis       Date:  2008-03       Impact factor: 2.830

3.  Ethics in human subjects research: do incentives matter?

Authors:  Ruth W Grant; Jeremy Sugarman
Journal:  J Med Philos       Date:  2004-12

4.  Who's doing the math? Are we really compensating research participants?

Authors:  Elizabeth Ripley; Francis Macrina; Monika Markowitz; Chris Gennings
Journal:  J Empir Res Hum Res Ethics       Date:  2010-09       Impact factor: 1.742

5.  For love or money? An exploratory study of why injecting drug users participate in research.

Authors:  C Fry; R Dwyer
Journal:  Addiction       Date:  2001-09       Impact factor: 6.526

6.  High resolution imaging of epithelial injury in the sheep cervicovaginal tract: a promising model for testing safety of candidate microbicides.

Authors:  Kathleen L Vincent; Nigel Bourne; Brent A Bell; Gracie Vargas; Alai Tan; Daniel Cowan; Lawrence R Stanberry; Susan L Rosenthal; Massoud Motamedi
Journal:  Sex Transm Dis       Date:  2009-05       Impact factor: 2.830

7.  The ethics of paying drug users who participate in research: a review and practical recommendations.

Authors:  Craig L Fry; Wayne Hall; Alison Ritter; Rebecca Jenkinson
Journal:  J Empir Res Hum Res Ethics       Date:  2006-12       Impact factor: 1.742

8.  Informative inducement: study payment as a signal of risk.

Authors:  Cynthia E Cryder; Alex John London; Kevin G Volpp; George Loewenstein
Journal:  Soc Sci Med       Date:  2009-11-18       Impact factor: 4.634

9.  Australian men's experiences during a microbicide male tolerance study.

Authors:  Susan L Rosenthal; Wendy Holmes; Lisa Maher
Journal:  AIDS Care       Date:  2009-01

10.  Using framework-based synthesis for conducting reviews of qualitative studies.

Authors:  Mary Dixon-Woods
Journal:  BMC Med       Date:  2011-04-14       Impact factor: 8.775

View more
  17 in total

1.  Increasing Asian American participation in clinical trials by addressing community concerns.

Authors:  Grace X Ma; Brenda Seals; Yin Tan; Sylvia Y Wang; Richard Lee; Carolyn Y Fang
Journal:  Clin Trials       Date:  2014-06       Impact factor: 2.486

2.  Randomized evaluation of trial acceptability by INcentive (RETAIN): Study protocol for two embedded randomized controlled trials.

Authors:  Dustin C Krutsinger; Jacqueline McMahon; Alisa J Stephens-Shields; Brian Bayes; Steven Brooks; Brian L Hitsman; Su Fen Lubitz; Celine Reyes; Robert A Schnoll; S Ryan Greysen; Ashley Mercede; Mitesh S Patel; Catherine Reale; Fran Barg; Jason Karlawish; Daniel Polsky; Kevin G Volpp; Scott D Halpern
Journal:  Contemp Clin Trials       Date:  2018-11-08       Impact factor: 2.226

3.  Payment expectations for research participation among subjects who tell the truth, subjects who conceal information, and subjects who fabricate information.

Authors:  Eric G Devine; Clifford M Knapp; Ofra Sarid-Segal; Sean M O'Keefe; Cale Wardell; Morgan Baskett; Ashley Pecchia; Katie Ferrell; Domenic A Ciraulo
Journal:  Contemp Clin Trials       Date:  2014-12-18       Impact factor: 2.226

4.  Why do people participate in epidemiological research?

Authors:  Claudia Slegers; Deborah Zion; Deborah Glass; Helen Kelsall; Lin Fritschi; Ngiare Brown; Bebe Loff
Journal:  J Bioeth Inq       Date:  2015-02-12       Impact factor: 1.352

5.  Incentives and payments in pragmatic clinical trials: Scientific, ethical, and policy considerations.

Authors:  Andrew Garland; Kevin Weinfurt; Jeremy Sugarman
Journal:  Clin Trials       Date:  2021-12       Impact factor: 2.486

6.  Re-engineering a Clinical Trial Management System Using Blockchain Technology: System Design, Development, and Case Studies.

Authors:  Yan Zhuang; Luxia Zhang; Xiyuan Gao; Zon-Yin Shae; Jeffrey J P Tsai; Pengfei Li; Chi-Ren Shyu
Journal:  J Med Internet Res       Date:  2022-06-27       Impact factor: 7.076

7.  Bioethical Issues in Providing Financial Incentives to Research Participants.

Authors:  David B Resnik
Journal:  Medicoleg Bioeth       Date:  2015-06-24

8.  Commonly performed procedures in clinical research: a benchmark for payment.

Authors:  Dinora Dominguez; Mandy Jawara; Nicole Martino; Ninet Sinaii; Christine Grady
Journal:  Contemp Clin Trials       Date:  2012-05-09       Impact factor: 2.226

9.  Retention strategies and factors associated with missed visits among low income women at increased risk of HIV acquisition in the US (HPTN 064).

Authors:  Danielle F Haley; Jonathan Lucas; Carol E Golin; Jing Wang; James P Hughes; Lynda Emel; Wafaa El-Sadr; Paula M Frew; Jessica Justman; Adaora A Adimora; Christopher Chauncey Watson; Sharon Mannheimer; Anne Rompalo; Lydia Soto-Torres; Zandraetta Tims-Cook; Yvonne Carter; Sally L Hodder
Journal:  AIDS Patient Care STDS       Date:  2014-04       Impact factor: 5.078

10.  Factors that impact on recruitment to randomised trials in health care: a qualitative evidence synthesis.

Authors:  Catherine Houghton; Maura Dowling; Pauline Meskell; Andrew Hunter; Heidi Gardner; Aislinn Conway; Shaun Treweek; Katy Sutcliffe; Jane Noyes; Declan Devane; Jane R Nicholas; Linda M Biesty
Journal:  Cochrane Database Syst Rev       Date:  2020-10-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.